"Titration" is the medical word for finding the right dose. Most ADHD medications start at a deliberately low dose and step up over weeks until you reach the dose that produces meaningful symptom reduction with tolerable side effects. This is a process — sometimes a lengthy one — and it's one of the places where patient/clinician communication makes the biggest difference.

The general clinical approach

The standard pattern across stimulants and non-stimulants is the same:

  1. Start low. Begin at the lowest typical starting dose, sometimes lower for sensitive patients.
  2. Go slow. Wait long enough at each dose to evaluate effect — typically 1–2 weeks for stimulants, 2–4 weeks for non-stimulants.
  3. Step up to effect. If symptoms aren't adequately controlled and side effects are tolerable, increase. Repeat.
  4. Stop at "good enough" with manageable side effects. The goal is not the maximum dose; it's the dose where benefit and side effects balance best.

The specific doses and timing depend on the medication. For Adderall XR, dose increases are usually 5–10 mg every 1–2 weeks. For Strattera, increases are weeks apart and require longer at each step to evaluate. Long-acting non-stimulants like Intuniv require careful blood-pressure monitoring.

What "the right dose" actually means

The right dose isn't defined by:

  • Your weight (although weight is a starting heuristic in pediatrics).
  • What worked for someone else with similar symptoms.
  • The middle of the FDA-approved range.
  • The maximum tolerable dose.

It's defined by the dose where:

  • Core ADHD symptoms are clinically reduced — focus, organization, time management, emotional regulation, distractibility.
  • Functional outcomes improve — work performance, school performance, relationships, daily life management.
  • Side effects are tolerable. Some side effects (mild appetite suppression, brief insomnia at start, dry mouth) are usually acceptable. Others (significant anxiety, persistent sleep disruption, mood blunting) often signal the dose is wrong.
  • The cardiovascular profile is acceptable — blood pressure, heart rate, and any cardiac symptoms are within safe ranges.

How long titration usually takes

  • Short-acting stimulants: 2–4 weeks to find a working dose. Once-a-day extended-release versions add another week or two if you switch to those.
  • Extended-release stimulants (Adderall XR, Concerta, Vyvanse): 4–6 weeks typically.
  • Non-stimulants (Strattera, Qelbree): 6–12 weeks for full effect; titration to effective dose takes 4–8 weeks plus another month at the target dose to evaluate.
  • Alpha-2 agonists (Intuniv, Kapvay): 4–8 weeks; slower in older patients.

This is why patience is critical. People who switch medications every 1–2 weeks because "it doesn't seem to be working" often never reach a therapeutic dose of any of them. Conversely, staying on a clearly-not-working dose for months without raising it wastes time.

When clinicians switch medications

Switching tends to happen for one of these reasons:

  • Inadequate efficacy at maximum tolerated dose. If you're at the FDA-approved max (or your individual tolerable max) and symptoms are still significant, switching makes sense.
  • Intolerable side effects that don't improve. Some side effects fade in 1–2 weeks. Some don't. Persistent significant side effects warrant a switch.
  • Discovery of a contraindication or comorbidity. New cardiovascular issue, new anxiety diagnosis, substance use concern.
  • Lifestyle mismatch. Long-acting was too long (couldn't sleep); short-acting wasn't long enough; needed more flexibility, etc.

The standard sequence in adults is often: try one stimulant class first (amphetamine or methylphenidate), if that doesn't work, try the other class, then move to non-stimulants if neither stimulant is suitable. Many clinicians use combinations — e.g. stimulant + alpha-2 agonist — for patients who get partial response.

What you can do to make titration faster and better

Three things matter:

1. Track. Daily.

Bring data to each visit. Time of dose, dose amount, focus rating, side effects, sleep, any functional outcomes worth noting. A 15-minute follow-up visit goes much further when your prescriber can see two weeks of data instead of asking "how was it?". This is exactly what trackers like trackadhd.org are designed for.

2. Ask before you change anything.

Don't double up doses, don't take meds at different times of day, don't take "drug holidays" without checking — all of these are reasonable adjustments your prescriber can make formally, but doing them informally muddies the data and can be unsafe. If something isn't working, message or call rather than experimenting.

3. Push back when it's warranted.

Some prescribers under-dose adults out of caution. Some over-dose because they're rushed. If your symptoms are clearly not adequately controlled and you're well below the FDA-approved max with no significant side effects, it's reasonable to ask about a dose increase. If you feel uncomfortable but the prescriber wants to keep going, ask about reducing or switching. You're a partner in the decision.

Objective measures during titration

Some clinicians use objective measures (Continuous Performance Tests, formal rating scales like the Conners, ADHD-RS) at intervals to add a less-subjective input alongside your daily log. CPT measurements before and after dose changes can show whether the medication is improving the specific cognitive metrics it's supposed to affect — independent of how you feel that day.

These are clinician-administered tools, not patient-administered. If you're curious whether your prescriber uses them, ask at your next visit.

See the full medication picture in the comparison tool — duration, onset, side effects, dose ranges all in one place.